Covaxin : The World Health Organization (WHO) may take a decision on including Bharat Biotech’s anti-COVID-19 vaccine Covaccine in the Emergency Use List (EUL) within the next four to six weeks. WHO chief scientist Soumya Viswanathan said in a webinar organized by the Center for Science and Environment (CSE) on Friday that Bharat Biotech, the manufacturer of covaccine, is uploading all its data on our portal. WHO is reviewing this vaccine.
Decision on covaccine may be done in four to six weeks
According to WHO guidelines, EUL is a process under which new or unlicensed products can be used in public health emergency situations. Swaminathan said, “EUL has a process in which a company has to complete Phase III trials and submit all the data to the regulatory department of WHO which is studied by an expert advisory group.” Bharat Biotech has already submitted the data and I hope a decision on the induction of the vaccine will be taken in four to six weeks.
Covid-19 Vaccine: Pfizer has not yet submitted an application to get its vaccine approved in India, big disclosure in the news quoting sources
Delta variant spreads very rapidly: WHO
Currently, WHO has approved for emergency use vaccines from Pfizer-BioNtech, AstraZeneca-SK Bio-Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm. Swaminathan said, “Right now we have approved six vaccines with EUL and have received recommendations from our strategic expert advisory group. We think the vaccine will be approved. Bharat Biotech has started putting their data on our portal and this will be the next vaccine which will be reviewed by our expert committee.” He also said that the delta form of the corona virus spreads rapidly. It is necessary to take two doses of the vaccine to protect against it. But even after getting vaccinated, the infection can spread. That’s why it is important to wear a mask and take other precautions.